These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37756050)

  • 41. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognition in prodromal Parkinson's disease.
    Liepelt-Scarfone I; Ophey A; Kalbe E
    Prog Brain Res; 2022; 269(1):93-111. PubMed ID: 35248208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biomarkers in Parkinson's disease: Advances and strategies.
    Delenclos M; Jones DR; McLean PJ; Uitti RJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and Medical Management of Parkinson Disease.
    Thaler A; Alcalay RN
    Continuum (Minneap Minn); 2022 Oct; 28(5):1281-1300. PubMed ID: 36222765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.
    Duty S; Jenner P
    Br J Pharmacol; 2011 Oct; 164(4):1357-91. PubMed ID: 21486284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonmotor features of Parkinson's disease subtypes.
    Marras C; Chaudhuri KR
    Mov Disord; 2016 Aug; 31(8):1095-102. PubMed ID: 26861861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.
    Knaryan VH; Samantaray S; Le Gal C; Ray SK; Banik NL
    J Neurochem; 2011 Aug; 118(3):326-38. PubMed ID: 21615738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson`s Disease.
    Kasabova-Angelova A; Tzankova D; Mitkov J; Georgieva M; Tzankova V; Zlatkov A; Kondeva-Burdina M
    Curr Med Chem; 2020; 27(12):2021-2036. PubMed ID: 30129404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can we image premotor Parkinson disease?
    Marek K; Jennings D
    Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prodromal Parkinson's disease: hype or hope for disease-modification trials?
    Mahlknecht P; Marini K; Werkmann M; Poewe W; Seppi K
    Transl Neurodegener; 2022 Feb; 11(1):11. PubMed ID: 35184752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The noradrenergic subtype of Parkinson disease: from animal models to clinical practice.
    Ray Chaudhuri K; Leta V; Bannister K; Brooks DJ; Svenningsson P
    Nat Rev Neurol; 2023 Jun; 19(6):333-345. PubMed ID: 37142796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current concepts in the management of Parkinson disease.
    Hayes MW; Fung VS; Kimber TE; O'Sullivan JD
    Med J Aust; 2010 Feb; 192(3):144-9. PubMed ID: 20121682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of interventions to improve family-staff relationships in the care of people with dementia in residential aged care: a systematic review protocol.
    Nguyen M; Pachana NA; Beattie E; Fielding E; Ramis MA
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):52-63. PubMed ID: 26657464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition and management of Parkinson's disease during the premotor (prodromal) phase.
    Truong DD; Wolters EC
    Expert Rev Neurother; 2009 Jun; 9(6):847-57. PubMed ID: 19496688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.
    Oikonomou P; van Wamelen DJ; Weintraub D; Aarsland D; Ffytche D; Martinez-Martin P; Rodriguez-Blazquez C; Leta V; Borley C; Sportelli C; Trivedi D; Podlewska AM; Rukavina K; Rizos A; Lazcano-Ocampo C; Ray Chaudhuri K
    Brain Behav; 2021 May; 11(5):e02086. PubMed ID: 33645912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrating Patient Concerns into Parkinson's Disease Management.
    Lim SY; Tan AH; Fox SH; Evans AH; Low SC
    Curr Neurol Neurosci Rep; 2017 Jan; 17(1):3. PubMed ID: 28102483
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.